On March 17, 2016, the Center for Strategic and International Studies (CSIS) Global Health Policy Center convened a pivotal forum […]
Tag: pharma
The Bio-Pharma Industry and Society: Balancing Global Health Access, Innovation, and Corporate Responsibility
The intersection of private enterprise and public health has long been a domain of intense scrutiny, debate, and delicate negotiation. […]
The Bio-Pharma Industry and Society: CSIS Global Health Policy Center Hosts Landmark Discussion on Affordability, Innovation, and Trust
WASHINGTON, D.C. — In an era marked by rapid scientific breakthroughs, escalating healthcare costs, and a growing erosion of public […]
The Bio-Pharma Industry and Society: Reimagining Global Health Stewardship and Corporate Responsibility
On March 17, 2016, the Center for Strategic and International Studies (CSIS) hosted a pivotal symposium titled The Bio-Pharma Industry […]
The Bio-Pharma Industry and Society: CSIS Global Health Policy Center Examines Affordability, Innovation, and Trust
The intersection of private enterprise and global public health has long been a subject of intense global debate. On March […]
CSIS Global Health Policy Center Hosts Landmark Discussion on Bio-Pharma Industry, Societal Goals, and Global Access to Medicines
The intersection of private enterprise and global public health has long been a subject of intense scrutiny, debate, and strategic […]
The Bio-Pharma Industry and Society: A CSIS Analysis of Corporate Reform and Global Health Equity
On March 17, 2016, the Center for Strategic and International Studies (CSIS) Global Health Policy Center convened a pivotal discussion […]
The Bio-Pharma Industry and Society: A CSIS Analysis of Corporate Responsibility and Global Access
On March 17, 2016, the Center for Strategic and International Studies (CSIS) Global Health Policy Center convened a pivotal forum […]
The Bio-Pharma Industry and Society: A High-Level Examination of Corporate Responsibility and Global Access
On March 17, 2016, the Center for Strategic and International Studies (CSIS) hosted a landmark policy forum titled "The Bio-Pharma […]
The Bio-Pharma Industry and Society: Balancing Innovation, Access, and Public Trust in Modern Healthcare
The intersection of commercial biopharmaceutical enterprises and broader societal welfare has long remained a focal point of intense global debate. […]
